Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Drug Product Stability01:16

Drug Product Stability

223
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
223
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

177
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
177
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

199
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
199

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Systemic viral vector vaccination induces brain resident memory T cells to drive anti-glioblastoma immunity.

bioRxiv : the preprint server for biology·2026
Same author

Retail cattle meat as a reservoir of multidrug-resistant Salmonella harboring β-lactamase genes in Sylhet, Bangladesh.

Veterinary research communications·2026
Same author

Impact of Low-Dose Cranberry Polyphenols on Gut Microbiota and Circulating Polyphenol Metabolites in Overweight and Obese Individuals (A Randomized Double-Blind Placebo-Controlled Clinical Pilot Study).

Food science & nutrition·2026
Same author

Antibiofilm Mechanisms and Applications of Natural Compounds.

Journal of food protection·2026
Same author

A Multidisciplinary Review of the Microbial, Functional, and Consumer Advancement of Indian Lassi.

Probiotics and antimicrobial proteins·2026
Same author

Fertile field emission response in scrambled SmNiO<sub>3</sub> nanopins.

Scientific reports·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 13, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

25.1K

Estrategia de desarrollo de probióticos centrada en la estabilidad y las consideraciones regulatorias

Hye Kim1, Ariful Haque1, Abdur Razzak1

  • 1Department of Food Science and Technology, Texas A&M University, College Station, Texas, USA.

Comprehensive reviews in food science and food safety
|January 6, 2026
PubMed
Resumen

El desarrollo de probióticos eficaces requiere tender puentes entre los hallazgos de laboratorio y las necesidades industriales. La evaluación estandarizada y la armonización regulatoria son clave para comercializar probióticos de próxima generación de manera segura y eficiente.

Palabras clave:
microencapsulaciónprobióticosmarcos regulatoriosestabilidaddesarrollo de cepas

Más Videos Relacionados

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

4.2K
The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.3K

Videos de Experimentos Relacionados

Last Updated: Jan 13, 2026

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods
08:38

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

25.1K
Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
05:45

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality

Published on: April 7, 2023

4.2K
The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.3K

Área de la Ciencia:

  • Microbiología y Biotecnología; Ciencia y Tecnología de los Alimentos; Ciencia Regulatoria

Sus antecedentes:

  • El desarrollo de cepas probióticas enfrenta desafíos para traducir la eficacia de laboratorio en estabilidad y rendimiento a escala industrial.; La demanda de los consumidores y los beneficios para la salud impulsan una investigación académica e industrial significativa en probióticos.; Existe una brecha entre los resultados funcionales demostrados y los requisitos para la comercialización, lo que dificulta la entrada al mercado.

Objetivo del estudio:

  • Revisar críticamente el proceso de desarrollo de probióticos, desde la selección de cepas hasta los marcos regulatorios.; Examinar el impacto de los factores estresantes de la producción en la viabilidad de las cepas probióticas y la efectividad de las estrategias de mejora de la resiliencia.; Comparar los sistemas regulatorios globales y destacar la necesidad de marcos de evaluación armonizados.

Principales métodos:

  • Revisión de la literatura de estudios sobre la selección de cepas probióticas y estrategias de resiliencia.; Análisis de los factores estresantes de la producción (calor, oxígeno, digestión) en la viabilidad de las cepas.; Análisis comparativo de los marcos regulatorios en EE. UU., la UE, Japón, Corea y China.

Principales resultados:

  • Estrategias adaptativas como el choque térmico y la microencapsulación muestran mejoras variables en la supervivencia de cepas (hasta 31 y 100 veces respectivamente), lo que resalta la especificidad de la cepa y los problemas de reproducibilidad.; Los factores estresantes de la producción afectan significativamente la viabilidad de los probióticos, lo que requiere estrategias específicas de resiliencia.; La heterogeneidad en las regulaciones globales para la clasificación, la seguridad y la justificación funcional complica el acceso al mercado internacional.

Conclusiones:

  • Los marcos de evaluación armonizados que integran la validación científica, el rendimiento industrial y el cumplimiento normativo son cruciales para desarrollar probióticos de próxima generación.; La colaboración sostenida entre la academia, la industria y los organismos reguladores es esencial para un progreso equilibrado en la eficacia, seguridad, escalabilidad y viabilidad económica de los probióticos.; Se necesitan enfoques estandarizados para superar la brecha de comercialización de los probióticos.